Figure 2 
TREATMENT AND MONITORING SCHEDULES 
Treatment or 
Evaluation 
Day of Study 
0 1 2 3 7 14 15 16 17 21 28 29 30 31 35 42 60 90 
Immunization 
X 
X 
X 
History/Physical 
Laboratory 
X 
X 
X 
X 
X 
X 
X X 
X X X X X 
X 
X 
X 
X 
X 
CBC 
PT, PTT 
Chem 20 
CH50 C3, C4 
UA 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
Viral/PCR Assays 
lOcc Green Top 
Serum DL-2 
Humoral Immunity 
10 cc Red Top 
Immunophenotypin 
Cellular Immunity 
Skin Testing 
X 
X 
X XX 
XXX 
X 
xj 
XX XX 
XXX 
X 
g 
50 cc Green 
Top 
X 
X 
X 
X 
X 
X 
X 
X 
X 
[ 636 ] 
Recombinant DNA Research, Volume 18 
